26 - Gilteritinib as Post-Transplant Maintenance for AML With Mutation of FLT3

Поділитися
Вставка
  • Опубліковано 11 вер 2024
  • Discussão do artigo: "Gilteritinib as Post-Transplant Maintenance for Acute Myeloid Leukemia With Internal Tandem Duplication Mutation of FLT3" de Levis M J Clin Oncol 2024
    Apresentado por: Dra Marcella Markman
    Discussão por: Dr. Lucas Salviano, Dr. Breno Aires, Dr. Matheus Puls, Dr. Gabriel Coquito, Dr. Pedro Arruda e Dr. Vinicius Molla.

КОМЕНТАРІ •